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Topological DNA damage, telomere
attrition and T cell senescence during
chronic viral infections
Yingjie Ji1,3, Xindi Dang1,2, Lam Ngoc Thao Nguyen1,2, Lam Nhat Nguyen1,2, Juan Zhao1,2, Dechao Cao1,2,
Sushant Khanal1,2, Madison Schank1,2, Xiao Y. Wu1,2, Zheng D. Morrison1,2, Yue Zou1, Mohamed El Gazzar1,
Shunbin Ning1,2, Ling Wang1,2, Jonathan P. Moorman1,2,4 and Zhi Q. Yao1,2,4*
Abstract
Background: T cells play a key role in controlling viral infections; however, the underlying mechanisms regulating
their functions during human viral infections remain incompletely understood. Here, we used CD4 T cells derived
from individuals with chronic viral infections or healthy T cells treated with camptothecin (CPT) - a topoisomerase I
(Top 1) inhibitor - as a model to investigate the role of DNA topology in reprogramming telomeric DNA damage
responses (DDR) and remodeling T cell functions.
Results: We demonstrated that Top 1 protein expression and enzyme activity were significantly inhibited, while the
Top 1 cleavage complex (TOP1cc) was trapped in genomic DNA, in T cells derived from individuals with chronic
viral (HCV, HBV, or HIV) infections. Top 1 inhibition by CPT treatment of healthy CD4 T cells caused topological DNA
damage, telomere attrition, and T cell apoptosis or dysfunction via inducing Top1cc accumulation, PARP1 cleavage,
and failure in DNA repair, thus recapitulating T cell dysregulation in the setting of chronic viral infections. Moreover,
T cells from virally infected subjects with inhibited Top 1 activity were more vulnerable to CPT-induced topological
DNA damage and cell apoptosis, indicating an important role for Top 1 in securing DNA integrity and cell survival.
Conclusion: These findings provide novel insights into the molecular mechanisms for immunomodulation by
chronic viral infections via disrupting DNA topology to induce telomeric DNA damage, T cell senescence, apoptosis
and dysfunction. As such, restoring the impaired DNA topologic machinery may offer a new strategy for
maintaining T cell function against human viral diseases.
Keywords: HBV, HCV, HIV, Topological DNA damage, Telomere attrition, T cell senescence
Introduction
T cells play a crucial role in defending the host from
pathogenic infections; however, the precise mechanisms
dampening their responses during chronic viral infections
remain incompletely understood. In studying the role of T
cell dysregulation in viral persistence in humans, we and
others have previously shown that chronic viral infections
can cause premature T cell aging and immune senescence,
as evidenced by the overexpression of aging markers, such
as p16ink4a, p21cip1, killer cell lectin-like receptor super-
family G 1 (KLRG1), and dual specific phosphatase 6
(DUSP6), the decline of aging-associated microRNA181
(miR181), and the particularly shortened telomeres, indi-
cating excessive cell proliferative turnover or inadequate
telomere maintenance during chronic viral infections [1–
13]. Telomeres are repeating hexameric DNA se-
quences (TTAGGG) that are found at the chromo-
some ends in association with a complex of shelterin
proteins [14]. Telomere integrity is a key feature of linear
chromosomes that preserve genome stability and function.
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Conversely, telomere attrition is a hallmark of cell senes-
cence that drives cell dysfunction and apoptosis [15–17].
The intertwined nature of two complementary DNA
structures is a unique feature of chromosomes to ensure
the storage and transmission of valuable genetic codes.
However, almost all types of DNA activities, including
gene replication, transcription, and recombination, lead to
topological entanglements that must be resolved to ensure
normal DNA transactions and subsequent cell functions
[18]. In order to prevent and correct these types of topo-
logical problems, topoisomerases (enzymes that modulate
the topology of DNA) bind to DNA and cut the phosphate
backbone of either one or both DNA strands by creating
transient breaks in the chromosomes [18]. This intermedi-
ate break allows the DNA to be untangled or unwound so
as to exert genetic activities, and, at the end of these pro-
cesses, the DNA backbone is resealed.
There are three main types of DNA topology: super-
coiling, knotting, and catenation. Correspondingly, the
human genome encodes three types of topoisomerases
to resolve such DNA entanglements: type IA (Top3α
and Top3β), type IB (nuclear Top1 and mitochondrial
Top1), and type IIA (Top2α and Top2β) [18]. Topoi-
somerases cleave and rapidly reseal one (type I) or two
(type II) DNA or RNA strands, generating a transient
break through which topological modifications can
occur [19]. This catalytic process is rather “dangerous”
in that it generates an intermediate in which the topo-
isomerase becomes covalently linked to the 3′ (type IB)
or 5′ (type IA and IIA) terminus of nucleic acids
through a phosphotyrosine linkage, designated as the
topoisomerase cleavage complex (TOPcc). Failure to
complete this catalytic cycle results in trapping of topo-
isomerase on DNA termini, generating protein-linked
DNA breaks (PDB) – a frequent event that causes cell
death [20–23]. Notably, the insertion of viral or bacterial
DNA into host chromosomes and other forms of recom-
bination also requires the action of topoisomerases.
Many drugs, such as broad-spectrum fluoroquinolone
antibiotics and chemotherapy drugs, operate through
disrupting or interfering with the function of bacterial or
cancer cell topoisomerases to create breaks in chromo-
somal DNA and to lead cell apoptosis or dysfunction
[24, 25]. Thus, although DNA topology is crucial for
normal cell function, its disruption may lead to DNA
damage response (DDR) and cell dysfunction or death.
While catalytic inhibition of topoisomerases has been
widely exploited to kill bacterial or cancer cells [24, 25],
the role and mechanisms of topoisomerases in repro-
gramming telomeric DDR and remodeling the function
of T lymphocytes during chronic viral infections remain
largely unknown. In this study, we explored the role of
topoisomerase I (Top 1) in telomeric DDR, T cell senes-
cence and dysfunction in a translational approach. We
provide evidence showing that T cells derived from pa-
tients with chronic hepatitis C virus (HCV), hepatitis B
virus (HBV), or human immunodeficiency virus (HIV)
infection exhibit significantly inhibited Top 1 protein ex-
pression and enzyme activity, accompanied by Top1cc
accumulation and trapping in genomic DNA. Using
camptothecin (CPT, a Top 1 inhibitor)-treated primary
T cells as a model, we demonstrate that disruption of
telomeric DNA topology promotes T cell senescence,
apoptosis, and dysfunction via enhancing DDR as a con-
sequence of Top1cc being formed and trapped at the
DNA break site. Importantly, T cells from virally infected
subjects with inhibited Top 1 activity were more vulner-
able to CPT-induced cell apoptosis, indicating an im-
portant role for Top 1 in maintaining DNA integrity and
securing cell survival. These results suggest that immu-
nocompromising viruses (HCV, HBV, and HIV) may
disrupt this T cell DNA topological processes as a
mechanism to dysregulate host immunity and estab-
lish chronic viral infection. Thus, restoring the im-
paired DNA topologic machinery may serve as a
novel strategy to protect T cells from unwanted DNA
damage and maintain immune competency.
Materials and methods
Subjects
The study subjects were composed of four populations:
37 chronically HCV-infected patients prior to antiviral
therapy; 29 chronically HBV-infected patients on anti-
viral treatment with undetectable viremia (HBV-DNA);
28 latently HIV-infected patients on antiretroviral ther-
apy (ART) with undetectable viremia (HIV-RNA); and
144 age-matched healthy subjects (HS), which were ob-
tained from Physicians Plasma Alliance (PPA), Gray, TN,
and negative for HBV, HCV and HIV infection. The
characteristics of the subjects included in this study are
described in Table 1.
Cell isolation and culture
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from whole blood by Ficoll (GE Heathcare, Piscat-
away, NJ) density centrifugation. CD4 T cells were isolated
from PBMCs using the CD4 T Cell Negative Isolation Kit
and a MidiMACS™ Separator (Miltenyi Biotec Inc., Au-
burn, CA). The isolated T cells were cultured in RPMI
1640 medium containing 10% FBS (Atlanta Biologicals,
Flowery Branch, GA), 100 IU/ml penicillin and 2mML-
glutamine (Thermo Scientific, Logan, UT) at 37 °C and 5%
CO2 atmosphere.
Flow cytometry
Intracellular IL-2 and IFN-γ cytokine production, DNA
damage marker γH2AX expression, PKH26-label CD4 T
cell proliferation, telomere length measured by florescence
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in-situ hybridization (Flow-FISH), and cell apoptosis assay
for Av/7AAD expression were analyzed by flow cytometry,
as described previously [26, 27]. The following reagents
were used in the assays: PE-labelled Av, IL-2, IFN-γ,
γH2AX (BD Biosciences, San Jose, CA), CD4-Alexa-647
(BioLegend, San Diego, CA), telomere probe TelC (CCCT
AACCCTAACCCTAA)-FITC (0.25 μg probe/mL, PNA
Bio, Newbury Park, CA).
RNA isolation and real-time RT-PCR
Total RNA was extracted from 1 × 106 CD4 T cells using
PureLink RNA Mini Kit (Invitrogen, Carlsbad, CA), and
cDNA was synthesized using High Capacity cDNA Re-
verse Transcription Kit (Applied Bio systems, Foster city,
CA) per the manufacturer’s instructions. Quantitative
real-time polymerase chain reaction (PCR) was performed
in triplicate as described previously [27]. Gene expression
was determined using the 2-ΔΔct method and normalized
to GAPDH levels, and is presented as fold changes. The
PCR primer sequences are shown in Table 2.
Western blotting
CD4 T cells (2 × 106) purified from HCV, HBV, or HIV pa-
tients and HS were used for western blot as described pre-
viously [26, 27]. Primary and secondary antibodies included
Top1, PARP1, γH2AX, TRF1, TRF2, TPP1, TIN2, RAP1,
POT1, ATM, pATM, CHK2, ATR, GAPDH, β-actin, and
horseradish peroxide-conjugated antibodies (Cell Signaling)
. Images were captured using ChemiDoc™ XRS+ System
(Bio-Rad). Protein band intensity was quantitated by the
Image Lab software (Bio-Rad).
Top 1 activity assay
The activity of Top 1 was measured by Topoisomerase 1
Assay Kit (Topogen, Inc., Cal No: TG1015–1, Buena
Vista, CO). Briefly, CD4 T cells were purified from pa-
tients and HS, and cell extracts were isolated from the
purified cells according to the instructions of the kit.
Samples were mixed with plasmid DNA substrate and
reaction buffer for 30 min at 37 °C, then loaded onto a
1% agarose gel with loading dye, and electrophoresed for
about 2 h at 5~10 V/cm before illuminating with a UV
transilluminator. The intensity of supercoiled DNA sub-
strate was measured by densitometry.
Top1cc detection
Top1cc was detected using the Human Topoisomerase ICE
Assay Kit (Topogen, Inc., Cal No: TG1020–1, Buena Vista,
CO 81211). The DNA purification protocol was modified
by combining ICE Assay Kit and PureLink™ Genomic DNA
Mini Kit (Thermo Fisher Scientific, Catalog number:
K182001, Waltham, MA 02451). Briefly, genomic DNA
sample were isolated from cell pellets using the extraction
buffers of ICE assay kit and then purified by the column of
PureLink™ Genomic DNA Mini Kit. The DNA samples
were loaded onto NC membranes by a vacuum pump,
which was incubated with primary anti-Top1cc antibody
from ICE assay kit, followed by western blotting as de-
scribed above.
Confocal microscopy
CD4 T cells were isolated and treated as described above,
followed by immunofluorescence staining using a method
described previously [26]. Rabbit anti-53BP1, anti-Ku70,
Table 1 Demographic information of the study participants
Subjects Numbers Age (Mean) Gender (M/F) Viral load and other characteristics
HCV 37 31–69 (52) 29/8 17,000-9,980,000 IU/ml, 26 GT1, 6 GT2, 5 GT3
HBV 29 22–61 (49) 20/9 All on antivirals with undetectable HBV-DNA
HIV 28 25–62 (46) 21/7 All on ART with undetectable HIV-RNA
HS 144 24–58 (44) 112/32 All tested negative for HCV, HBV, and HIV
Table 2 PCR primers used in this study
Primers Forward Reverse
TOP1 5′-TCCGGAACCAGTATCGAGAAGA-3′ 5′-CCTCCTTTTCATTGCCTGCTC-3’







GAPDH 5′-TGCACCACCAACTGCTTAGC-3’ 5′- GGCATGGACTGTGGTCATGAG-3’
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anti-RAD51 or anti-Top1cc (Cell Signaling) and mouse
TRF1 (Thermo Fisher) were used as primary antibodies
and anti-rabbit IgG-Alexa Fluor 488 and anti-mouse IgG-
Alexa Fluor 555 (Invitrogen) were used as secondary anti-
bodies. The cells were washed and mounted with DAPI
Fluoromount-G (SouthernBiotech, Birmingham, AL). Im-
ages were acquired with a confocal laser-scanning inverted
microscope (Leica Confocal, Model TCS sp8, Germany).
Statistics
The data were analyzed using Prism 7 software, and are
presented as mean ± SEM or median with interquartile
range. Comparisons between two groups were made
using unpaired Student’s t test, or paired T test. P-values
< 0.05, < 0.01, or < 0.001 were considered statistically sig-
nificant or very significant, respectively.
Results
Top 1 expression and activity are inhibited in CD4 T cells
from individuals with chronic viral infections
Chronic viral (HCV, HBV, HIV) infections are character-
ized by T cell exhaustion, senescence, and cellular dys-
function [1–13], but the underlying mechanisms remain
incompletely understood. We have recently discovered
that these dysfunctional, senescent T cells exhibit pro-
nounced DNA damage and telomere erosion [26, 27].
Given the crucial role of DNA topology in securing gen-
omic integrity and cell survival [20–23], we used a transla-
tional approach to explore the mechanisms of DNA
damage and T cell dysregulation by examining the expres-
sion level of Top 1 in CD4 T cells derived from individuals
with chronic viral (HCV, HBV, HIV) infection and HS. As
shown in Fig. 1a, chronically HCV, HBV, or HIV-infected
patients exhibited a significantly lower level of Top 1 pro-
tein expression in their CD4 T cells compared to age-
matched HS, as determined by western blotting. To deter-
mine whether Top 1 inhibition occurs at the transcrip-
tional or translational level, we measured Top 1 mRNA
levels by real-time RT-PCR in CD4 T cells derived from
these subjects. As shown in Fig. 1b, the mRNA levels of
Top 1 in CD4 T cells isolated from these patients showed
little changes compared to age-matched HS, suggesting
that Top 1 inhibition during chronic viral infections pri-
marily occurs at the translational level.
Human Top 1 is a type 1B topoisomerase that can





Fig. 1 Inhibition of Top 1 expression and activity in CD4 T cells during chronic viral infections. a Top 1 protein expression in CD4 T cells isolated
from HCV-, HBV-, and HIV-infected individuals versus HS. Representative imaging and summary data of western blot are shown. The Top 1
densitometry values were normalized to β-actin and then HS. b Top 1 mRNA expression, measured by real-time RT-PCR, in CD4 T cells isolated
from virally infected individuals and HS. c Dose-dependent Top 1 enzyme activity measured by a plasmid (pHOT1)-based Top 1 Assay Kit. d Top 1
activity in CD4 T cells isolated from HCV-, HBV-, and HIV-infected individuals versus HS. Representative imaging and summary data of Top 1-
mediated digestion of supercoiled DNA substrate (normalized to HS) are shown (n = number of subjects) to be tested. e Top1cc detected in
genomic DNA isolated from CD4 T cells of virus-infected patients versus HS. HS, health subject; n, number of subjects
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or negative supercoiled DNA [20]. Thus, we employed
a plasmid (pHOT1)-based Top 1 Assay Kit (TopoGEN,
Inc.) to measure Top 1 activity in CD4 T cells derived
from patients with chronic viral infection. As shown in
Fig. 1c (left to right), where the Top 1-relaxed linear
plasmid DNA (pHOT1) served as positive control (+),
the untreated supercoiled plasmid DNA served as nega-
tive control (−), and an escalated amount of nuclear
extract-treated plasmid DNA exhibited a pattern from
supercoiled DNA substrate to linear DNA topoisomers
in 1% agarose gel in a dose-dependent manner. Based
on this result, we used 1.6 μg of nuclear extracts, which
can resolve > 50% supercoiled DNA substrate, to com-
pare the Top 1 enzyme activity in virus-infected pa-
tients versus HS. While the HS-derived nuclear extracts
efficiently relaxed the supercoiled plasmid DNA, the
nuclear extracts derived from HCV-, HBV- and HIV-
infected patients failed to completely relax the plasmid
DNA (Fig. 1d).
Top 1 is a prototypical eukaryotic enzyme that relaxes
supercoiled DNA without the need for cellular energy
(ATP). During the course of its normal catalytic cycle, Top
1 nicks one DNA strand and allows rotation around the
intact strand, and then reseals the DNA backbone. This
DNA relaxation activity plays an important role in restor-
ing DNA topology, replication, transcription, and viral in-
tegration [18–25]. Collisions of this catalytic cycle with
the Top1cc formed during DNA nicking are thought to
produce further DNA damage, ultimately leading to cell
death [20–23]. To determine if Top1 inhibition resulted in
Top1cc buildup and trapping in their T cell chromosomes,
we measured Top1cc in genomic DNA isolated from CD4
T cells of virus-infected patients and HS using a monoclo-
nal antibody that specifically recognizes covalent Top 1-
DNA complexes, but not free Top 1 or DNA, using im-
munoblotting [28]. As shown in Fig. 1e, a significant
amount of Top1cc was detected in CD4 T cells isolated
from HCV, HBV, HIV-infected patients compared to HS.
These results, in conjunction with our previous findings
of T cell exhaustion and senescence with poor cellular
functions during chronic viral infections [1–4, 26, 27],
suggest that these dysfunctional, senescent T cells from
chronically virus-infected individuals have topological ab-
errancies, i.e., Top 1 inhibition, leading to Top1cc
accumulation.
Top 1 inhibition by CPT in healthy T cells induces
telomeric DNA damage, cell apoptosis and dysfunction
Top 1 is targeted by a class of widely utilized anticancer
drugs [18, 19]. CPT intercalates into DNA at the Top 1
catalytic site, inhibiting the reseal step and shifting the
equilibrium toward Top1cc accumulation [29]. To ex-
plore the role of Top 1 inhibition in DNA damage and
T cell dysregulation, we employed CPT-treated primary
CD4 T cells as a model. Since Top1cc can be selectively
trapped by CPT, which binds at the Top 1-DNA inter-
face, leading to potent transcription- and replication-
blocking DNA lesions causing cytotoxicity [29]. To this
end, CD4 T cells were isolated from HS and exposed to
varying concentrations of CPT (0, 1, 2.5, 5, 10 μM) for
different time points (24, 48, 72 h), followed by the
measurement of cell apoptotic death by flow cytometry.
As shown in Fig. 2a, CPT-treated healthy T cells exhib-
ited a dose- and time-dependent increases in Annexin V
(Av, left panel) and 7-Aminoactinomycin D (7AAD, right
panel) levels compared to cells treated with dimethyl
sulfoxide (DMSO) control. We also measured T cell
functions by flow cytometric analysis of intracellular
cytokine production and cell proliferation following T
cell receptor (TCR) stimulation and with or without
CPT treatment. As shown in Fig. 2b, intracellular IL-2
and IFN-γ cytokine productions were significantly inhib-
ited in human T cells exposed to CPT compared to
DMSO control in the presence of anti-CD3/CD28 (1 μg/
ml) stimulation for 3 days. Moreover, a significantly
inhibited T cell proliferation, as evidenced by the delayed
PKH26 dye dilution, was observed in human T cells ex-
posed to CPT compared to control, in the presence of
TCR stimulation for 5 days (Fig. 2c).
To determine whether CPT-induced DNA damage
might be a primary reason for T cell dysfunction, we
treated CD4 T cells with CPT or control for 3 days,
followed by measuring the phosphorylated histone H2AX
(γH2AX), a marker for DNA damage. As shown in Fig. 2d,
a significant γH2AX upregulation was detected in CPT-
treated CD4 T cells compared to the control, as deter-
mined by flow cytometry. Notably, these findings (CPT-in-
duced T cell apoptosis, cytokine or proliferation inhibition
via DDR in vitro) recapitulate the T cell dysregulation due
to exhaustion and senescence we and others have ob-
served in chronic viral infections in vivo [1–13, 26, 27].
Therefore, CPT-treated T cells could serve as a model to
study the role and mechanisms of Top 1-mediated DNA
topological aberrancies in T cell dysregulation.
Human T cell telomeres shorten at a rate of 50~100
base pairs per cell division, acting as a molecular clock to
control the replicative capacity before entering cell cycle
arrest, senescence, or apoptosis [17]. Since mammalian
telomeres consist of triple guanine repeats (TTAGGG)
that are very sensitive to oxidative DNA damage [30, 31],
we speculated that CPT-induced DNA damage may ex-
tend to the telomeres that we have shown to have telo-
meric DNA damage in T cells derived from chronically
virus-infected individuals [26, 27]. Notably, following gen-
otoxic insult, 53BP1 is recruited to the DNA damage site
on chromosomes as well as telomeres and acts as a dock-
ing station for other mediator or adaptor proteins to form
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microscopically visible nuclear foci (DNA damage foci)
[32, 33]. A single 53BP1-formed focus represents hun-
dreds to thousands of 53BP1 proteins that are recruited
around at least one DNA strand break [32]. Thus, iden-
tifying damaged telomere induced foci (TIF) is typically
regarded as a hallmark of telomeric DNA damage [33].
To determine telomeric DNA damage in CPT-treated T
cells, we compared the number of TIFs per nucleus and
the percentages of cells with > 3 TIFs, by examining the
co-localization of 53BP1/TRF1 (telomeric repeat-
binding factor 1) using confocal microscopy. As shown
in Fig. 2e, the numbers of TIF per nucleus were signifi-
cantly higher in CD4 T cells exposed to CPT vs.
DMSO-treated control. The percentage of T cells with
> 3 TIFs was also higher in CPT-treated cells compared
to the control. Taken together, these results suggest
that CPT-induced topological DNA damage may
cause cell apoptosis and T cell dysfunction, thus em-
phasizing the role of telomere integrity in securing T
cell survival and providing a robust model to study
Top 1-mediated telomere topological DNA damage
and repair machinery.
CPT-induced DNA damage involves Top1cc accumulation,
PARP-1 cleavage, and transcription-dependent, ubiquitin-
mediated top 1 proteolysis
Physiologically, Top 1 relaxes intertwined DNA by produ-
cing transient Top1cc during DNA transcription. After
DNA relaxation, Top1cc reverses rapidly and Top 1 is re-
leased as the DNA re-ligates. However, Top1cc can be
trapped under pathological conditions, and a consequence
of transcription-blocking Top1cc is the production of
Top1-lined PDBs [29]. To determine whether CPT-
induced T cell inhibition is primarily due to Top 1 sup-
pression, we examined Top 1 protein expression in CD4
T cells treated with CPT by western blot. As shown in
Fig. 3a, Top 1 protein expression was significantly inhib-
ited in CD4 T cells exposed to CPT. In addition, Top 1 en-
zyme activity was also inhibited in CD4 T cells treated by
CPT compared to the control (Fig. 3b). To determine
whether Top1cc accumulated during DNA nicking in T
cells exposed to CPT, we treated primary CD4 T cells with
a high dose of CPT (50 μM) for a short period of time (45
min), followed by genomic DNA isolation and immuno-






Fig. 2 Top 1 inhibition induces telomeric DNA damage, T cell apoptosis, and T cell dysfunction. a Dose- and time-dependent induction of Av
and 7-AAD expression in CD4 T cells treated with varying concentrations of CPT for 1, 2, and 3 days, analyzed by flow cytometry. b Inhibition of
IL-2 and IFN-γ expression in CD4 T cells treated with or without 1 μM CPT for 3 days, followed by flow cytometry. c Flow cytometry of T cell
proliferation as determined by PKH26 dye dilution in CD4 T cells treated with or without 1 μM CPT for 5 days. d γH2AX expression in CD4 T cells
treated with or without 1 μM CPT for 3 days followed by flow cytometry. e Confocal microscopy of Telomeric DNA damage foci to assess co-
localization of 53BP1 and TRF1 on telomeres, in CD4 T cells treated with or without 1 μM CPT for 2 days. Representative images and summary
data for TIFs per nucleus as well as percentage of cells with > 3 TIFs are shown
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genomic DNA in CPT-treated T cells compared to the
DMSO control (Fig. 3c). These observations recapitulated
the Top 1 inhibition seen in patients with chronic viral in-
fections (Fig. 1).
Trapped Top1cc can cause DNA strand breaks [34, 35],
and removal of these breaks depends on the tyrosyl-DNA
phosphodiesterase-1 (TDP1) excision pathway [22, 36–
40]. Notably, Top1cc excision by TDP1 requires Poly
ADP-Ribose Polymerase 1 (PARP1), an enzyme that cata-
lyzes the transfer of ADP-ribose onto target proteins and
plays an important role in cell apoptosis, DNA damage re-
pair and chromosomal stability [40–42]. PARP1 binds to
TDP1, leading to TDP1 stabilization and its recruitment
at the sites of Top1cc-induced PDB to initiate the repair-
ing process. To determine whether CPT-induced DNA
damage in T cells involves PARP1 cleavage, we measured
PARP1 in CPT-treated CD4 T cells. As shown in Fig. 3d,
while the total PARP1 level was reduced, the cleaved form
of PARP1 was significantly induced by the CPT treatment,
which correlated with DNA damage and cell apoptosis.
Since PARP1 binding to TDP1 is crucial for Top1cc re-
moval [40–42], we then assessed whether inhibition of
PARP1 would increase DNA damage in CPT-treated T
cells. As shown in Fig. 3e, compared to the DMSO-treated
control (1), CPT treatment (2) significantly inhibited Top
1 level but increased PARP1 cleavage and γH2AX expres-
sion. Whereas the PARP1 inhibitor ABT-888 (also known
by its trade name, Veliparib, as a chemotherapeutic) [43]
did not block (but feedback increased) Top 1 expression,
it augmented the levels of PARP1 and γH2AX in DMSO
(3) as well as CPT-treated (4) CD4 T cells (4), indicating
that PARP1 is a down-stream molecule acting together
with CPT in the Top 1 signaling pathway.
Collisions of transcription complexes with CPT-induced
Top1cc are thought to produce DNA damage and cell
apoptosis. Consistent with this model, we speculated that
inhibition of transcription would diminish the DNA dam-
age of Top 1 poisons. To test whether CPT-induced, Top
1-mediated DNA damage is transcription-dependent, we
examined Top 1, PARP1, and γH2AX levels in CD4 T cells
treated with CPT in the presence or absence of the tran-
scription inhibitor flavopiridol (FLV). As shown in Fig. 3f,
compared to DMSO-treated control (1), CPT treatment
(2) inhibited Top 1, but increased PARP1 cleavage and
γH2AX expression. As expected, while FLV inhibited Top
1 and significantly boosted PARP1 cleavage and γH2AX
expressions (3), inhibition of transcription prevented
CPT-induced Top 1 suppression and further induction of
a
e f g h
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Fig. 3 Top 1 inhibition, Top1cc and PARP1 induction, and transcription-dependent ubiquitination of Top 1 in CPT-treated T cells. a Western blot
analysis of Top 1 inhibition in CD4 T cells treated with or without 1 μM CPT for 3 days. b Top 1 enzyme activity measured in CD4 T cells exposed to
CPT and control for 3 days. c Top1cc detected in genomic DNA from CD4 T cells treated with or without CPT (50 μM for 45min). d PARP1 induction in
CD4 T cells with or without CPT treatment. e Western blot analysis of Top 1, PARP1, and γH2AX levels in CD4 T cells with or without CPT treatment in
the presence or absence of APRP-1 inhibitor (ABT-888). f Western blot analysis of Top 1, PARP1, and γH2AX levels in CD4 T cells with or without CPT
treatment in the presence or absence of transcription inhibitor (FLV). g Western blot analysis of Top 1, PARP1, and γH2AX levels in CD4 T cells with or
without CPT treatment in the presence or absence of ubiquitin isopeptidase inhibitor (G5). h Western blot analysis of Top 1, PARP1, and γH2AX levels
in CD4 T cells with or without CPT treatment in the presence or absence of proteasomal inhibitor (MG-132)
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PARP1 or γH2AX levels in CD4 T cells (4). These results
indicate that CPT induces a transcription-dependent DDR
in human T lymphocytes.
As we have shown above, Top 1 inhibition primarily
occurs at the protein level (Fig. 1). Indeed, Top1cc-
mediated transcription blockade triggers Top 1 degrad-
ation by the ubiquitin/proteasome system [44]. Thus, we
further examined whether the protein degradation ma-
chinery could contribute to the observed Top 1 protein
inhibition and occurrence of transcription-dependent
DNA damage. As shown in Fig. 3g, compared to the
DMSO-treated control (1), CPT treatment inhibited Top
1 level, but induced PARP1 and γH2AX levels (2). Intri-
guingly, inhibition of ubiquitin by isopeptidase inhibitor
(G5), which causes depletion of free nuclear ubiquitin
[45], prevented Top 1 degradation in CPT-treated T cells
(4). We then assessed whether inhibiting the ubiquitin
system could prevent DDR signaling. Notably, the ubi-
quitin inhibitor G5 could induce PARP1 cleavage and
γH2AX expression in primary CD4 T cells (3); however,
G5 treatment prevented further induction of PARP1 and
γH2AX levels in CPT-exposed cells (4). Similarly, inhib-
ition of proteolysis by a proteasome inhibitor (MG132),
which prevented CPT-induced Top 1 degradation, also
prevented CPT-induced accumulation of PARP1 and
γH2AX (Fig. 3h), suggesting that topological DNA dam-
age depends upon Top 1 ubiquitination and proteasome
degradation. Taken together, these results indicate that
the CPT-induced topological DNA damage involves the
transcription-dependent, ubiquitin-mediated Top 1
proteolysis.
CPT-induced top 1 inhibition induces telomere attrition
via disruption of telomerase activity and shelterin
protection
We and others have recently shown that T cell exhaus-
tion and senescence during chronic viral infections are
associated with accelerated telomere erosion, a hallmark
of cell aging or immune senescence [4–7, 26, 27]. To de-
termine whether CPT-treated T cells mirror the telo-
mere loss seen in patients with viral infections, we
measured the telomere length in CPT-treated T cells by
Flow-FISH. As shown in Fig. 4a, significant telomere at-
trition was observed in CD4 T cells exposed to CPT
compared to the DMSO-treated control. Notably, telo-
meres are replenished by telomerase that comprises tel-
omerase RNA (TR) and human telomerase reverse
transcriptase (hTERT) - the catalytic unit of telomerase
[46]. Telomerase regulation has been studied extensively
in malignant cells, and recently, hTERT measurement
has also been employed to study T cells that have a high
rate of turnover, especially during pathogenic infections
[47, 48]. We have recently measured telomerase expres-
sion and activities in CD4 T cells derived from patients




Fig. 4 Top 1 inhibition induces telomere erosion via suppression of telomerase activity and shelterin proteins. a Telomere length, measured by
Flow-FISH, in CD4 T cells with or without CPT treatment for 5 days. b Telomerase hTERT expression, measured by real-time RT-PCR, in CD4 T cells
treated with or without CPT. c Telomerase activity, measured by TRAP assay, in CD4 T cells treated with or without CPT. d Shelterin proteins,
measured by western blot, in CD4 T cells treated with or without CPT. e Shelterin mRNA, measured by real-time RT-PCR, in CD4 T cells treated
with or without CPT
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hTERT expression remained unchanged, but its activity
was significantly suppressed and failed to be recruited
onto telomeres to maintain telomere integrity (unpub-
lished observations). Here, we further measured hTERT
expression by real-time RT-PCR and telomerase activ-
ities by TRAP assay in CPT-treated CD4 T cells. As
shown in Fig. 4b and c, CPT-treated T cells exhibited an
unchanged hTERT expression but remarkably inhibited
telomerase activity when compared to the DMSO-
treated control, which recapitulates the observations in
T cells from patients with HCV and HIV infection.
It is well-known that telomeres are protected by shel-
terin complexes. To explore the mechanisms of telo-
mere erosion in CPT-treated T cells, we examined the
integrity of the telomeric shelterin complex, which
comprises six telomere-associated proteins, including
telomeric repeat-binding factors 1 and 2 (TRF1 and
TRF2), repressor/activator protein 1 (RAP1), telomere
protection protein 1 (TPP1), protection of telomere 1
(POT1), and TRF1-interacting nuclear protein 2
(TIN2), where they act together in shaping and safe-
guarding telomeres from erosion [49, 50]. As shown in
Fig. 4d, TRF1 and pTRF2 levels were significantly lower
than control levels. TPP1 and TIN2 levels were slightly
downregulated, whereas RAP1 and POT1 remained un-
changed or slightly upregulated, in CD4 T cells after
the CPT treatment. However, the mRNA expression of
these shelterin proteins remained essentially un-
changed, except TPP1, by this treatment (Fig. 4e).
These results recapitulate the data we observed in CD4
T cells derived from HCV and/or HIV-infected patients
versus HS [27] (unpublished observations). Since the
primary functions of TRF1/TRF2/TPP1/TIN2 sub-
complexes are to protect telomeres from unwanted
DNA damage and to recruit telomerase to telomeres,
their inhibition would lead to telomere uncapping or
deprotection, and a telomerase that is unable to access
or function at telomeres.
CPT-mediated top 1 inhibition and DDR involves dynamic
activation and depletion of DNA repair kinases
Accumulation of DNA damage activates the protein kin-
ase ataxia telangiectasia mutated (ATM), an enzyme crit-
ically involved in repairing DNA damage for cell survival
[51, 52]. ATM, along with ataxia telangiectasia Rad3-
related (ATR), is the pinnacle kinase of the DNA repair
signaling cascade, which is important for DNA repro-
gramming and T cell rearrangement [53, 54]. To investi-
gate the involvement of DNA repair enzymes in CPT-
mediated Top 1 inhibition and topological DDR, we ex-
amined the kinetic expressions of ATM and ATR, in
conjunction with DNA damage and repair markers,
γH2AX and PARP1, in CD4 T cells following CPT
treatment for different time points (1 h, 3 h, 6 h, 1 d, 3 d,
5 d). As shown in Fig. 5a, an increase in PARP1 cleavage
was seen in CPT-treated T cells at all time points. Also,
γH2AX was increased in the early phase (1~6 h) of CPT
treatment; however, it decreased and eventually could
not be detected in CD4 T cells at later times after CPT
treatment (3~5 d), which is consistent with a previous
report indicating that CPT treatment promotes DDR
and activates DNA protein kinase c (DNA-PKc), and
that ATM enhances phosphorylation of H2AX at an
early phase and then triggers the ubiquitination cascade
and proteasome degradation of γH2AX at double strand
break (DSB) sites at later stages [55]. Indeed, ATM and
pATM were increased in response to DDR in the early
phase (1~6 h) and then gradually became deficient in the
later phase of CPT treatment (3~5 d). Correspondingly,
the downstream checkpoint kinase 2 (CHK2) was also
upregulated in the early phase and became progressively
depleted in the late phase of CPT treatment. Likewise,
ATR exhibited the same pattern as ATM in response to
the acute and persistent DDR induced by CPT treat-
ment. In conjunction with our recent findings of ATM
insufficiency in CD4 T cells in chronic HCV and HIV in-
fection [26] (unpublished observations), these data indi-
cate that CPT-induced, Top1-mediated topological DDR
involves a dynamic activation and depletion of DNA re-
pair kinases.
Next, we studied the role of these DNA repair kinases
(ATM/ATR) in T cell topological DDR to gain insight
into their functional relevance. To identify which of
these kinases induces γH2AX in topological DDR, we
assessed whether γH2AX phosphorylation is prevented
by the specific inhibitors of these kinases in CPT-
induced TOP 1 inhibition. Since γH2AX induction was
primarily observed in the early phase (3~6 h) of CPT
treatment (Fig. 5a), we chose to measure its level in
CD4 T cells after 3 h of CPT treatment. As shown in
Fig. 5b, CPT treatment inhibited Top 1 expression.
Correspondingly, the expression of γH2AX was in-
creased by the CPT-induced topological DDR (2 vs.1).
ATMi (KU60019) did not affect TOP 1 level, but sig-
nificantly reduced γH2AX level (3 vs.1). Interestingly,
ATMi reduced the CPT-mediated γH2AX induction (4
vs. 2), suggesting that ATMi inhibits DDR. In addition,
while ATRi did not affected TOP 1 level as well, it re-
duced the level of γH2AX (5 vs.1), which is consistent
with the ATMi treatment, suggesting that these kinase
inhibitors inhibit DDR. However, ATRi treatment fur-
ther reduced the CPT-mediated Top 1 downregulation
and, concurrently, further induced the γH2AX expres-
sion (6 vs.2). We observed similar results in repeated
experiments, and these are consistent with previous re-
ports [55], suggesting that ATM, but not ATR, is impli-
cated in the induction of γH2AX in CPT-treated cells.
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CPT induces Top1cc accumulation to prevent DNA repair
molecule recruitment to the DNA damage sites
We have recently found that the non-homologous end
joining (NHEJ) pathway, rather than the homologous re-
combination (HR) pathway of DNA repair, participates in
the ATM-mediated telomeric DNA damage repair (un-
published data). However, how DSBs accumulate in cells
despite the presence of DNA repair proteins remains un-
known. It is well-known that Ku70 and Ku80 make up the
Ku heterodimer, which binds to DNA-DSB ends and is re-
quired for the NHEJ pathway of DNA repair. It is also re-
quired for V(D)J recombination, which utilizes the NHEJ
pathway to promote antigen diversity in the mammalian
immune system. In addition to its role in NHEJ, Ku is in-
volved in telomere length maintenance [56]. It has been
reported that mutant mice with deficient Ku70 exhibit
premature aging [57], suggesting that Ku70 plays an im-
portant role in longevity assurance and that the reduced
ability to repair DNA-DSB causes early aging. To deter-
mine the role of the NHEJ pathway in repairing CPT-
induced telomeric DNA damage, we measured the Ku70-
dependent, damaged telomere induced foci (TIF) in CD4
T cells exposed to CPT or DMSO for 6 or 72 h using con-
focal microscopy. Surprisingly, we could not identify any
Ku70/TRF1 co-localization in cells treated with CPT or
DMSO control (Fig. 5c), suggesting that Ku 70 failed to be
recruited to the damaged telomeres. We also examined
possible involvement of the HR pathway in the CPT-
induced DSB repair. Since RAD51 is involved in the
search for homology and strand pairing stages of the
process [58, 59], we used confocal microscopy to examine
the RAD51/TRF1 co-localization in CD4 T cells exposed
to CPT or DMSO for 6 or 72 h. Again, we did not find
any difference between control and treatment (Fig. 5d).
Since CPT induces cytotoxicity by trapping Top1cc at
the Top 1-DNA covalent sites, which in turn interacts
with advancing replication or transcription complexes to
generate lethal DNA lesions, we further hypothesize that
Top1cc may accumulate and occupy the DSB ends, pre-
venting the recruitment of DNA repair molecules to the
damaged sites in T cells. To test this possibility, we exam-
ined the CPT-induced, Top1cc-mediated dysfunctional
telomere foci using a monoclonal antibody that specific-
ally recognizes covalent Top 1-DNA complexes, but not
free Top 1 or DNA, using confocal microscopy [28]. We
found a significant increase in Top1cc/TRF1-formed TIFs
in T cells exposed to CPT compared to the DMSO-treated
control (Fig. 5e). Also, we observed Top1cc accumulation
at damaged telomeres in T cells treated with KML001 (a
telomere-targeting drug that can inhibit Top 1 expression
a
b c d e
Fig. 5 Top 1-mediated DDR involves dynamic activation and deficiency of DNA repair kinases. a Western blot analysis of kinetic alterations in
PARP1, γH2AX, pATM, ATM, CHK2, and ATR levels in CD4 T cells treated with or without CPT for different time points. Representative images and
summary data from 3 independent experiments are shown. b Western blot of Top 1 and γH2AX expression in CD4 T cells treated with or without
CPT in the presence or absence of ATMi or ATRi. c Representative images from confocal microscopy examination of co-localization of Ku70 and
TRF1 in CD4 T cells treated with CPT or DMSO for 3 days. d Representative images of co-localization of RAD51 and TRF1 in CD4 T cells treated
with CPT or DMSO for 3 days. e Representative images of co-localization of Top1cc and TRF1 in CD4 T cells treated with CPT or DMSO for 3 h
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and induce Top1cc), but not in cells treated with the
ATM inhibitor (KU60019)-induced telomeric DNA dam-
age, which is not involving in Top1cc induction but via
the NHEJ pathway for DNA damage repair; unpublished
observations). Taken together, these results suggest that
CPT induces Top1cc accumulation and trapping at the
DSB sites, which may prevent DNA repair molecule re-
cruitment and inhibit DNA damage repair.
T cells from individuals with chronic viral infection are
more vulnerable to CPT-induced cell apoptosis
Since chronically virus-infected patients suffer from defi-
ciency in the Top 1 enzyme and exhibit more DNA dam-
age within their CD4 T cells, we hypothesized that these T
cells were more vulnerable to CPT-mediated cell apop-
tosis. We thus examined the apoptotic susceptibility of
CD4 T cells derived from virus-infected patients versus
age-matched HS upon CPT treatment. Indeed, CD4 T
cells isolated from HCV-, HBV-, and HIV-infected pa-
tients exhibited higher rates of cell apoptosis (Av expres-
sion) than those from HS (Fig. 6a). Correspondingly, a
higher rate of cell death (7-AAD expression) was observed
in CD4 T cells from virally infected patients versus HS
(data not shown). These results, in conjunction with our
previous in vivo findings of T cell exhaustion and senes-
cence in virus-infected individuals [26, 27], suggest that
Top1-mediated topological DNA damage, if left unre-
paired, can trigger both cell apoptosis and cell death.
Discussion
T cells play a pivotal role in controlling pathogenic infec-
tion and vaccine responses. In chronic viral infections,
particularly in immunosuppressive HCV, HBV, and HIV
infections; T cells are however essentially always dys-
functional and vaccine responses are often blunted [60].
We and others have previously shown that T cells from
chronically virus-infected individuals are prematurely
aged or senescent due to telomere attrition and erosion
[1–13, 26, 27], but the underlying mechanisms for T cell
telomeric DNA damage and repair remain unclear. Since
Top 1 is required to remove DNA supercoiling gener-
ated during cell overexpansion, and TOP1cc can become
a b
Fig. 6 Sensitivity of CD4 T cells derived from virally infected individuals and HS to CPT-induced apoptosis, and a novel model of virus-induced
disruption of DNA topology in T cell dysregulation. a Vulnerability of CD4 T cells, derived from virally infected individuals and HS, to the CPT-
induced apoptosis as measured by flow cytometry. b A working model for Top 1-mediated DDR and T cell dysregulation during HIV infection.
The intertwined nature of two complementary DNA often lead to topological entanglements during gene transcription and replication that must
be resolved to ensure normal gene transactions and cell functions. In order to prevent and correct these types of topological problems, Top 1
binds to DNA and cuts one DNA strand, allowing the DNA to be untangled or unwound so as to exert genetic activities. According on our
results, the immunomodulatory virus (HCV, HBV, HIV) infection and/or CPT treatment can inhibit Top 1 protein expression and enzymatic activity,
leading to Top1cc trapped at the DNA breaks including telomere termini and causing topological DNA damage, telomere loss, cell senescence
and apoptosis. This regulatory cascade represents a novel molecular mechanism that underlies T cell senescence and T cell dysfunction, which
contribute to viral persistence and vaccine non-responsiveness in human viral infections
Ji et al. Immunity & Ageing           (2019) 16:12 Page 11 of 15
trapped during gene transcription to cause Top 1-linked
PDB [20–23], we hypothesized that T cell DNA topology
may be altered during viral infections to cause DDR as a
mechanism of virus-mediated immune dysregulation.
In this study, we employed T cells isolated from virus-
infected individuals and primary T cells treated with CPT
as a model to specifically induce transcription-blocking
Top1cc in order to obtain insights into the molecular
mechanisms underlying both DNA damage and repair pro-
cesses. We demonstrate that: 1) CD4 T cells derived from
chronically HBV, HCV, and HIV-infected individuals with
immune dysfunction exhibit an inhibition of Top 1 enzyme
expression and activity, leading to accumulation of Top1cc
and DNA damage, including telomere erosion; 2) CPT-
induced Top 1 inhibition, Top1cc accumulation, topo-
logical DNA damage, telomere uncapping and erosion, T
cell apoptosis and dysfunctions recapitulate what we ob-
serve in T cells during chronic viral (HCV, HBV, HIV) in-
fections, emphasizing the role of Top 1 in maintaining
telomeric DNA integrity and securing T cell survival and
function; 3) CPT-induced topological DDR is achieved via
transcription-dependent, ubiquitin-mediated Top 1 prote-
olysis, involving dynamic ATM activation followed by defi-
ciency - Top1cc accumulation at the DSB sites may block
the recruitment of DNA repair proteins and inhibit DNA
damage repair; and 4) T cells from virally infected subjects
with lower Top 1 activity are more vulnerable to CPT-
induced topological DNA damage and cell apoptosis, indi-
cating an important role for Top 1 in preventing unwanted
DNA damage and securing cell survival.
Although accumulation of DNA damage and failure to
be repaired may affect cell survival and function, the mo-
lecular signaling pathways in T lymphocytes in the context
of chronic viral infections remain largely unknown. Our re-
sults support a model, as depicted in Fig. 6b, in which Top
1 inhibition and Top1cc accumulation block transcription
elongation, which triggers ubiquitin-mediated Top 1 prote-
olysis and the generation of Top1cc-linked PDBs. Defective
repair of these PDBs can further give rise to DDR, which
leads to ATM activation and phosphorylation of its down-
stream substrates such as CHK2 and p53. ATM also acti-
vates 53BP1 and γH2AX assembling into nuclear DNA
damage foci and promotes ubiquitination of multiple sig-
naling molecules in the process of DNA damage and repair.
Notably, several E3 ligases have been reported for γH2AX
(RNF2, RNF8, RNF168) and for Top 1 (Cullin3, Cullin4A/
4B, BRCA1) ubiquitination and proteasomal degradation
[45, 61]. Our findings that Top 1 inhibition and γH2AX
production in CPT-treated T cells depend both on tran-
scription and on Top 1 ubiquitination suggest that they
arise during the repair of Top1cc and that this pathway
feedback to enhance Top1cc repair after Top 1-linked PDB
induction. Moreover, inhibition of PARP1, which is re-
quired for TDP1 excision of Top1cc [40–42], also increases
transcription-dependent Top 1-PDB and γH2AX induction
following Top1cc stabilization. This model is supported by
our recent findings showing that ATM deficiency [26] and
TRF2 uncapping [27] increases DNA damage, telomere at-
trition, T cell senescence and apoptosis, likely due to in-
creased Top1cc levels, as demonstrated in this study in
both T cells isolated from chronic viral infections or treated
with CPT, leading to T cell dysfunction.
While the mechanisms that lead to Top 1 inhibition
during chronic viral infections remain unclear, multiple
factors may play a role in this process. Topological DNA
damage might occur spontaneously in replicating T cells
under physiological conditions, but Top1cc can be
trapped under a broad range of pathological conditions,
including Top 1 inhibition by immunomodulating vi-
ruses (HCV, HBV, HIV, and coinfection with CMV or
EBV), by oxidative base damage, by alkylation with car-
cinogenic compounds or antiviral agents, or by ribonu-
cleotide misincorporations during genetic activities in
over-proliferating T cells in response to low grade,
chronic inflammatory stimuli [20–25]. Therefore, these
transcriptional Top 1-linked PDBs may have a marked
impact on senescent T cells, leading to reprogramming
DDR and remodeling of the T cell fate that arise from i)
defective removal of Top1cc, ii) deprotection of telo-
meres by shelterins [27], iii) failure of telomere elong-
ation by telomerase dysfunction, and iv) deficiency of
DNA damage repair by ATM [26]. T cells might be par-
ticularly prone and vulnerable to Top 1-mediated topo-
logical DNA damage and cell apoptosis as a result of
high rates of oxygen consumption, which produces large
amounts of reactive oxygen species (ROS), which we
have recently found to be significantly increased in T
cells of virus- (HCV and HIV)-infected individuals. In-
deed, ROS can stabilize Top1cc to cause topological
DNA damage and activate the ATM signaling pathway
[28, 29, 62, 63]. Hence, our findings suggest a new para-
digm in which topological DNA damage contributes to
the T cell senescence, apoptosis and immune evasion oc-
curring during chronic viral infections.
This study focuses on the major blood-borne patho-
gens, HBV, HCV, and HIV. It would be noteworthy to
investigate whether topological DNA damage and pre-
mature T cell aging also occur in the setting of other
chronic viral infections, such as CMV and EBV. These
infections often display similar phenotypic characteris-
tics to those observed in HIV, HBV and/or HCV infec-
tion, such as exhausted and senescent T cells, and this
would be especially relevant in immunocompromised
hosts. Our investigation in CD4 T cells is informative be-
cause they represent the lymphocyte helper subsets of
the immune system, aiding in CD8 T cell and B cell re-
sponses, and their survival critically affects the process
of immune aging. We expect to see the same topological
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DNA damage in CD8 T cells, which often display more
prominent dysfunctions with exhaustion and senescence
phenotype. It should be pointed out that while Top 1 in-
hibition and Top1cc accumulation explain both telomeric
DNA damage and cell apoptosis, they may function as a
double-edged sword, resulting in both overwhelming cell
death in acute infection and immune tolerance or immune
suppression in chronic infection. Nevertheless, these find-
ings provide the first demonstration of a pivotal role for
Top 1 in DDR and new molecular insights into immuno-
modulation during chronic viral infections through disrup-
tion of Top 1 to induce telomeric DDR, T cell senescence,
apoptosis, and dysfunction. Most importantly, it provides a
potential strategy to restore impaired DNA topological ma-
chinery as a means to improve T cell functions and vaccine
responses during human viral infections.
Conclusion
We and others have previously shown that chronic viral
infections could cause premature T cell aging or immune
senescence with accelerated telomere erosion, but the
mechanisms underlying DNA damage and telomere loss
remain unclear. For the first time to our knowledge, here
we report that Top 1 was inhibited, and TOP1cc was
trapped in genomic DNA, in T cells from patients with
chronic HBV, HCV, and HIV infection. We then used
healthy T cells treated with CPT as a model to investigate
the role and mechanisms of DNA topology in reprogram-
ming telomeric DDR and T cell functions. We demon-
strated that Top 1 inhibition caused topological DNA
damage, telomere attrition, and T cell apoptosis or dys-
function by inducing Top1cc accumulation and failure in
DNA repair, thus recapitulating T cell dysregulation in the
setting of chronic viral infections. This study reveals a
novel mechanism for immunomodulation by viral infec-
tions via disrupting DNA topology, telomere integrity, and
T cell biology. Therefore, restoring the impaired DNA
topologic machinery may offer a new strategy to maintain
T cell function against human viral diseases.
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